INmune Bio Inc. - stock earnings
INMB Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 6, 2024 BeforeMarket | - / -0.5300000000 | - | - / 30000 | - |
INMB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.4 million USD | 28000 USD |
| 2023Q3 | -8.6 million USD | 43000 USD |
| 2023Q2 | -6.5 million USD | 46000 USD |
| 2023Q1 | -6.6 million USD | 38000 USD |
| 2022Q4 | -6.0 million USD | 97000 USD |
| 2022Q3 | -8.0 million USD | 98000 USD |
| 2022Q2 | -7.3 million USD | 16000 USD |
| 2022Q1 | -7.3 million USD | 163000 USD |
| 2021Q4 | -9.7 million USD | 163000 USD |
| 2021Q3 | -9.5 million USD | 14000 USD |
| 2021Q2 | -6.7 million USD | 4 USD |
| 2021Q1 | -4.6 million USD | 4000 USD |
| 2020Q4 | -3.2 million USD | 10916 USD |
| 2020Q3 | -4.7 million USD | ? USD |
| 2020Q2 | -2.1 million USD | ? USD |
| 2020Q1 | -2.1 million USD | ? USD |
| 2019Q4 | -2.3 million USD | 77.7 million USD |
| 2019Q3 | -3.1 million USD | ? USD |
| 2019Q2 | -392083 USD | ? USD |
| 2019Q1 | -1.9 million USD | ? USD |
| 2018Q4 | -1.9 million USD | ? USD |
| 2018Q3 | -1.5 million USD | ? USD |
| 2018Q2 | -6.2 million USD | ? USD |
| 2018Q1 | -2.8 million USD | ? USD |
| 2017Q4 | -428235 USD | ? USD |
| 2017Q3 | -307527 USD | ? USD |
| 2017Q1 | 30000 USD | ? USD |
INMB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.0 million USD | 155000 USD |
| 2022 | -28.6 million USD | 374000 USD |
| 2021 | -30.3 million USD | 181000 USD |
| 2020 | -12.1 million USD | 10916 USD |
| 2019 | -9.1 million USD | 77.7 million USD |
| 2018 | -12.4 million USD | ? USD |
| 2017 | -831486 USD | ? USD |
| 2016 | -277491 USD | ? USD |
| 2015 | -48870 USD | ? USD |
INMB
Price: $11.57
52 week price:
Earnings Per Share: -1.67 USD
P/E Ratio: -8.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 49961
Market Capitalization: 219.9 million